
Algocell offers an AI-powered platform for bioprocess optimization, targeting cell-based companies in industries like pharmaceuticals, novel foods, agriculture, bioplastics, and biofuels. The platform creates a 'Digital Twin' of bioprocesses using hybrid biological and engineering models, combined with AI optimization algorithms and in-silico simulations. This technology significantly reduces experimental trial-and-error by up to 70%, accelerating time to market and improving production efficiency. Algocell's solution provides real-time insights for in-manufacturing optimization, stabilizes process efficiency and product quality, and minimizes batch-to-batch variability. The company aims to be an industry leader in Bioprocess 4.0, enabling companies to achieve their fullest potential through model-based control and optimization.

Algocell offers an AI-powered platform for bioprocess optimization, targeting cell-based companies in industries like pharmaceuticals, novel foods, agriculture, bioplastics, and biofuels. The platform creates a 'Digital Twin' of bioprocesses using hybrid biological and engineering models, combined with AI optimization algorithms and in-silico simulations. This technology significantly reduces experimental trial-and-error by up to 70%, accelerating time to market and improving production efficiency. Algocell's solution provides real-time insights for in-manufacturing optimization, stabilizes process efficiency and product quality, and minimizes batch-to-batch variability. The company aims to be an industry leader in Bioprocess 4.0, enabling companies to achieve their fullest potential through model-based control and optimization.